Deal facts
- Buyer
- Tonix Pharmaceuticals Holding Corp.
- Target
- Upsher Smith Laboratories, LLC
- Deal value
- USD 27,000,000
- Announced
- 3 July 2023
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash
Sources
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Tonix Pharmaceuticals Holding Corp. completes acquisition of Upsher Smith Laboratories, LLC
Item 1.01. Entry into a Material Definitive Agreement. On June 30, 2023, in connection with the Asset Purchase, as defined below, Tonix Medicines, Inc., a Delaware corporation (“ Acquisition Sub ”), a wholly-owned subsidiary of Tonix Pharmaceuticals Holding Corp, Inc. (the “ Company ”, and together with Acquisition Sub, the “ Purchaser ”), entered into a Transition Services Agreement (the “ Transi
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business
Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…
- Buyer
- Dolby Medical Home Respiratory Care Limited (Vivisol)
- Target
- Air Liquide Healthcare Limited’s home oxygen services business
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
RSLGH, LLC to acquire RYTHM, Inc.
RSLGH, LLC has agreed to acquire RYTHM, Inc., a healthcare company based in the United States, in a strategic acquisition valued at $109.5 million. The transaction invol…
- Buyer
- RSLGH, LLC
- Target
- RYTHM, Inc.
- Deal value
- USD 109,500,000
- Deal type
- strategic acquisition
Ensysce Biosciences, Inc. to acquire Cy Biopharma, Inc.
Ensysce Biosciences, Inc. has agreed to acquire Cy Biopharma, Inc. in a strategic acquisition within the healthcare sector. The transaction was announced on 5 August 202…
- Buyer
- Ensysce Biosciences, Inc.
- Target
- Cy Biopharma, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Profusa, Inc. to acquire G3 Vision Labs Inc.
Profusa, Inc. has agreed to acquire G3 Vision Labs Inc. in a strategic acquisition within the healthcare sector. The transaction involves the exchange of shares as the p…
- Buyer
- Profusa, Inc.
- Target
- G3 Vision Labs Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Tonix Pharmaceuticals Holding Corp.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive